Clinical Trial Update: A Real World Study to Globally Assess Disease Burden in Adolescent and Adult Participants With Alopecia Areata, Vitiligo, or Hidradenitis Suppurativa

View source ↗

Summary

A real-world, global study to assess disease burden in adolescents and adults with alopecia areata, vitiligo, or hidradenitis suppurativa.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alopecia Areata
• Hidradenitis Suppurativa
• Vitiligo

Snippet

Sponsor: AbbVie | Conditions: Non-Segmental Vitiligo (NSV), Alopecia Areata | Status: RECRUITING